| 000 | 01713 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516131647.0 | ||
| 264 | 0 | _c20130913 | |
| 008 | 201309s 0 0 eng d | ||
| 022 | _a1479-6821 | ||
| 024 | 7 |
_a10.1530/ERC-12-0117 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aChiang, Ying-Cheng | |
| 245 | 0 | 0 |
_aEpigenetic silencing of BLU through interfering apoptosis results in chemoresistance and poor prognosis of ovarian serous carcinoma patients. _h[electronic resource] |
| 260 |
_bEndocrine-related cancer _cApr 2013 |
||
| 300 |
_a213-27 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aAntineoplastic Agents _xpharmacology |
| 650 | 0 | 4 | _aApoptosis |
| 650 | 0 | 4 | _aBiomarkers, Tumor |
| 650 | 0 | 4 | _aCarcinoma, Ovarian Epithelial |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCisplatin _xpharmacology |
| 650 | 0 | 4 | _aCytoskeletal Proteins |
| 650 | 0 | 4 | _aDrug Resistance, Neoplasm |
| 650 | 0 | 4 | _aEpigenomics |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGene Silencing |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMethylation |
| 650 | 0 | 4 |
_aNeoplasms, Glandular and Epithelial _xgenetics |
| 650 | 0 | 4 |
_aOvarian Neoplasms _xgenetics |
| 650 | 0 | 4 |
_aPaclitaxel _xpharmacology |
| 650 | 0 | 4 | _aPrognosis |
| 650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
| 650 | 0 | 4 |
_aTumor Suppressor Proteins _xgenetics |
| 700 | 1 | _aChang, Ming-Cheng | |
| 700 | 1 | _aChen, Pao-Jen | |
| 700 | 1 | _aWu, Meei-Maan | |
| 700 | 1 | _aHsieh, Chang-Yao | |
| 700 | 1 | _aCheng, Wen-Fang | |
| 700 | 1 | _aChen, Chi-An | |
| 773 | 0 |
_tEndocrine-related cancer _gvol. 20 _gno. 2 _gp. 213-27 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1530/ERC-12-0117 _zAvailable from publisher's website |
| 999 |
_c22428796 _d22428796 |
||